RE:RE:Terry is now Advisor to BNXT, BioNextI am also suprised that he is promoting BNXT which currently has a 4 to 5 cent Shareprice.They will require a lot of money to carry out the clinical trials started by IMV,much more than the bit they have raised recently.Not sure why Terry is involved.I was invested in IMV several years ago because of the compelling evidence behind their DPX technology.Perhaps Terry is trying to attract some big pharma to finance the trials. Merck was previously involved but must have given up,not a helpful sign.